Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDM1005 vs placebo in type 2 diabetes mellitus
CTR20260321Phase 3Active
- Sponsor
- 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.)
- Start
- Mar 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of poterepatide in type 2 diabetes mellitus (T2DM), sponsored by 杭州中美华东制药有限公司 (Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.). Started Mar 2026; status: active.
02
Drugs
poterepatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20260321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260321.